Show simple item record

Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer

dc.contributor.authorCrawley, D
dc.contributor.authorChandra, A
dc.contributor.authorLoda, M
dc.contributor.authorGillett, C
dc.contributor.authorCathcart, P
dc.contributor.authorChallacombe, B
dc.contributor.authorCook, G
dc.contributor.authorCahill, D
dc.contributor.authorSanta Olalla, A
dc.contributor.authorCahill, F
dc.contributor.authorGeorge, G
dc.contributor.authorRudman, S
dc.contributor.authorVan Hemelrijck, M
dc.date.accessioned2018-03-05T15:01:29Z
dc.date.issued2017-12
dc.identifier494
dc.identifier.citationBMC Cancer, 2017, 17 (1)
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1551
dc.identifier.eissn1471-2407
dc.identifier.doi10.1186/s12885-017-3458-3
dc.languageeng
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.titleMetformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer
dc.typeJournal Article
rioxxterms.versionofrecord10.1186/s12885-017-3458-3
rioxxterms.licenseref.startdate2017-12
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfBMC Cancer
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume17
pubs.embargo.termsNot known
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail
Name:
rm.PNG
Size:
63.31Kb
Format:
PNG image
Description:
Supporting information
View/Open

This item appears in the following collection(s)

Show simple item record